Cerebroplacental ratio changes in selective twin growth restriction after antenatal steroids: impact on neonatal outcomes
Tuesday, April 9, 2024
4:58pm – 5:05pm
Location: 410
Authors: Andrea Lugo-Morales, Baylor College Of Medicine Jessian Munoz, Baylor College of Medicine Romain Corroenne, Bcm Cara Buskmiller, Baylor College of Medicine Roopali Donepudi, Baylor College of Medicine Magdalena Sanz Cortes, Baylor College of Medicine Ahmed Nassr, Baylor College of Medicine / Texas Children’s Hospital
Discover groundbreaking insights at our presentation, "Cerebroplacental Ratio Changes in Selective Twin Growth Restriction after Antenatal Steroids: Impact on Neonatal Outcomes." This captivating study delves into the world of monochorionic diamniotic (MCDA) twin pregnancies, uncovering the implications of cerebroplacental ratios (CPR) after Betamethasone (BMZ) administration in cases of selective fetal growth restriction (sFGR).
Our retrospective analysis of 27 MCDA twin cases reveals remarkable findings. Despite BMZ administration, CPR remained largely unchanged in growth-restricted twins, suggesting minimal hemodynamic shifts. Yet, the consequences are profound: infants with a CPR < 1 face a 13.1-fold increased risk of emergent cesarean section. This presentation is an eye-opener for healthcare professionals, shedding light on a potentially invaluable tool for assessing sFGR in MCDA twins.
But the impact doesn't stop there. Attendees will also gain insight into neonatal outcomes, where lower CPRs ( < 1) correlate with lower Apgar scores and birth weights in both growth-restricted and non-growth-restricted twins. The implications are clear: understanding and monitoring CPR is crucial in predicting neonatal health and guiding clinical decisions.
Do not miss the opportunity to witness a study that could redefine how we approach sFGR in MCDA twins, potentially saving lives and improving perinatal outcomes. Join us at the presentation and be at the forefront of innovative medical knowledge.